Treating cancer patients in a pandemic

A pandemic doesn’t politely knock and wait outside the infusion suite. It shows up uninvited, sits in the lobby, and makes everyonepatients, caregivers,
cliniciansdo math they never signed up for: risk of infection vs. risk of delay, today’s safety vs. tomorrow’s outcomes.
And oncology, a field already fluent in hard conversations, suddenly had to become fluent in airflow, video visits, and “Can your caregiver join by speakerphone?”

In the KevinMD podcast episode “Treating cancer patients in a pandemic,” oncologist Don S. Dizon describes the emotional core of oncology: being a witness
to a diagnosis that can change a life in an instantand then helping someone find a way forward anyway. A pandemic doesn’t replace that role. It intensifies it.

Why cancer care hits different during an outbreak

Not every medical visit is optionalbut cancer visits are often time-sensitive in ways that don’t pause just because the world is on fire. Many cancers grow,
spread, or become harder to treat if therapy is postponed too long. At the same time, some cancer treatments weaken the immune system, raising the odds that
a respiratory virus can go from “miserable” to “medically dangerous” fast.

Risk isn’t equal across cancers or treatments

“Cancer patient” is not one uniform category. Someone in long-term remission and someone receiving intensive chemotherapy live in very different risk universes.
Blood cancers can be especially complicated because the disease (and certain therapies) can reduce the immune cells that make protective antibodies.

That’s why pandemic-era oncology leaned heavily on personalization: treatment goals (curative vs. disease control), patient factors (age, other medical conditions),
local virus levels, and the specific therapy’s immune effects. The theme was consistent: keep care movingwhile reducing unnecessary exposure.

The new “standard of care”: don’t add a preventable infection to an existing diagnosis

During COVID-era peaks, oncology clinics re-engineered the patient journey like an airport security lineexcept the “contraband” was an invisible virus and the
stakes were, you know, slightly higher than losing a shampoo bottle.

• Pre-visit triage: symptom screening, exposure questions, and rapid testing pathways when appropriate.
• Right-size the visit: in-person for exams, infusions, procedures; virtual for discussions, follow-ups, symptom checks when safe.
• Clinic flow redesign: spaced scheduling, fewer people in waiting rooms, and “text us from the car” check-ins.
• Protection layers: masking when virus levels are high, ventilation upgrades where feasible, and clear instructions patients can actually follow.

Vaccination planning became part of cancer care logistics, tooespecially for people who are moderately or severely immunocompromised. The practical approach:
don’t delay vaccination unnecessarily, and coordinate timing when possible around immune-suppressing therapy, because “best protection” beats “perfect timing”
when a virus is actively circulating.

What can waitand what really can’t

The hardest pandemic oncology decisions weren’t about masks or video platforms. They were about time: How long is too long to wait?
The answer depended on the cancer type, stage, biology, and treatment intent.

Common pandemic triage buckets (with real-world examples)

• Cannot wait (curative or urgent): aggressive cancers, rapidly progressing symptoms, treatments where delay is known to worsen outcomes.
  
  Example: starting therapy for certain acute leukemias or treating spinal cord compression.
• Short delay may be reasonable: situations where a brief postponement is unlikely to change long-term outcomes, especially if virus risk is extreme.
  
  Example: some surveillance visits or low-risk procedures that can be safely rescheduled.
• Modify, don’t pause: keep the treatment goal intact while changing how care is delivered.
  
  Example: switching some check-ins to telehealth, consolidating labs and imaging, or adjusting supportive care to reduce ER visits.

One underappreciated pandemic lesson: delays can cause harm outside the cancer center, too. When people skip routine medical visits, cancers may be
diagnosed later, at more advanced stages, which can mean more intensive treatment down the road. Oncology teams weren’t just fighting a virus; they were also
fighting the quiet problem of delayed diagnosis.

How oncology adapted without “lowering the bar”

Oncology doesn’t get to say, “We’ll circle back when the outbreak is over.” Instead, it learned to bend care pathways without breaking standards.
The goal wasn’t to do less medicineit was to do medicine differently.

Telehealth grew up overnight (and yes, it still needed pants)

Telehealth became the default for many conversations that don’t require hands-on exams: reviewing scan results, discussing side effects, medication checks,
counseling on symptoms, survivorship planning, and second opinions.

But oncology telehealth is not just a Zoom link. Clinics built workflows for:
documenting symptoms reliably, triaging red flags, coordinating local labs or imaging, and making sure patients could still access urgent in-person evaluation.
Regulatory and payment flexibility also matteredbecause “great idea” is not a business model unless it’s covered.

Less time in the clinic: the “efficiency that respects safety” playbook

Oncology teams looked for safe ways to reduce visits without compromising outcomes, including:

• Bundling care: labs + visit + treatment on the same day when feasible.
• Remote check-ins: symptom questionnaires and nurse calls to catch issues early.
• Medication logistics: refills streamlined, oral therapies shipped when appropriate, and supportive meds coordinated to reduce extra trips.
• Caregiver participation by phone/video: so patients didn’t have to choose between support and safety rules.

Radiation, surgery, and systemic therapy: smart modifications

Different specialties found different levers. In some situations, radiation schedules were adjusted to reduce the number of visits when clinically appropriate.
Surgeons and medical oncologists sometimes used bridging strategieslike treating with systemic therapy first in select caseswhen operating rooms were limited or
infection risk was unusually high. The guiding principle stayed the same: preserve the treatment goal, minimize avoidable exposure.

Clinical trials: keeping research ethical when the world is chaotic

Clinical trials are not a “nice-to-have” add-on; for many patients, they’re a best option. During pandemic disruptions, trial teams faced a delicate balancing act:
protect participant safety, preserve data integrity, and keep access fair.

Pandemic-era adjustments included remote consent processes, virtual follow-ups, using local providers for certain checks when travel was difficult, shipping some
oral study drugs to participants, and expanding remote monitoring/audits where feasible. These changes didn’t just patch a crisisthey offered a blueprint for making
trials less burdensome long-term, especially for patients who live far from major academic centers.

Communication: the real PPE is clarity

Here’s the part no one brags about on hospital tour brochures: the pandemic multiplied the number of emotionally loaded conversations in a single day.
“You have cancer.” “We’re still treating it.” “Your caregiver can’t come inside.” “We’ll call them together.” “Yes, the plan is still the planjust with more steps.”

In the KevinMD episode, Dr. Dizon describes oncology as witnessing fear, acceptance, perseverance, and terrorsometimes within the same hour. A pandemic doesn’t
change the human response to cancer; it changes the conditions under which that response unfolds.

What helped patients most often wasn’t a perfect script. It was a consistent structure:

• Explain the “why” behind clinic rules and changes, not just the rules themselves.
• Be specific about what should trigger a call, a test, or urgent evaluation.
• Name the trade-offs honestly: delaying treatment can carry risk, but so can infection.
• Make a plan patients can repeat back, because stress eats short-term memory for breakfast.

Equity: pandemics don’t hit evenly, and neither does access to cancer care

A telehealth-first strategy is only as good as a patient’s ability to use it. Broadband gaps, language barriers, lack of a private space, time off work, childcare,
and transportation all shaped who benefited from pandemic-era changes.

The most resilient cancer programs built “multiple doors” into care: video when possible, phone when needed, and in-person access when clinically necessary.
They also partnered with community clinics and local labs to keep essential monitoring accessible.

What a pandemic-ready oncology clinic looks like now

The best pandemic innovations weren’t flashy. They were boringin the best waylike checklists that work and systems that don’t collapse when a variable changes.
Many cancer centers now keep a standing “surge plan” that can scale up or down based on local conditions.

A practical checklist clinics tend to keep (or wish they had kept)

• Tele-triage built into scheduling so urgent symptoms are caught early.
• Clear infection-control protocols that can tighten during spikes and relax responsibly when risk drops.
• Medication continuity planning for supply disruptions and pharmacy delays.
• Clinical trial flexibility with documented pathways for remote visits and monitoring when appropriate.
• Caregiver inclusion strategies (speakerphone, video, written summaries) so patients aren’t isolated.
• Staff support systems to reduce burnoutbecause exhausted teams make more mistakes, and cancer care doesn’t forgive sloppy.

The podcast takeaway: oncology is still oncologyeven when the world changes

The KevinMD podcast episode doesn’t frame cancer care in a pandemic as a heroic montage (thankfullyreal life has fewer slow-motion high-fives).
It frames it as a continuation of the core oncology mission: meet the patient where they are, tell the truth with compassion, and build a path forward.

In a pandemic, that path includes more logistics: vaccines, masks during surges, telehealth check-ins, sometimes fewer visitors in the building.
But the heart of the work is unchanged: help a person carry something heavy without pretending it isn’t heavy.

Conclusion

Treating cancer patients in a pandemic is a masterclass in adaptive medicine. It blends infection prevention, careful triage, flexible delivery models,
and relentless communicationwhile keeping outcomes as the north star. The most important lesson may be this: cancer care doesn’t stop for a crisis.
It evolves through it.

If you or someone you love is in active treatment, the smartest move is to talk with the oncology team about individualized risk, vaccination timing,
what symptoms should trigger urgent care, and which visits can be handled remotely. Good cancer care during an outbreak isn’t about choosing between
safety and treatmentit’s about designing a plan that protects both.

Experiences from the frontlines (composite stories) extended section

The clearest pandemic memories in oncology often aren’t the headlines. They’re the small, repeated moments that changed how care feltday after day.
The following are composite vignettes, stitched from common scenarios clinicians and patients described during pandemic peaks, with details generalized
to protect privacy.

1) The parking-lot waiting room. A patient arrives early, not because they love punctuality, but because they’re nervous about new rules.
The front desk texts: “Please wait in your car. We’ll message when the room is ready.” It’s efficient, safer, and a little surreallike curbside pickup,
except what you’re picking up is chemotherapy and courage. When the text comes, the patient walks in alone. Their partner stays outside, holding a phone,
ready to join the visit on speaker. The clinician learns to pausenot because the plan is uncertain, but because it matters that everyone hears it together.

2) The visit that becomes three visits. Before the pandemic, a follow-up might have been one appointment. Now it’s a sequence:
a telehealth check-in to review symptoms, a quick lab stop scheduled to avoid crowds, and an infusion slot timed like a relay handoff.
The patient says, “I feel like I need a project manager just to have cancer.” The nurse laughsgentlyand replies, “You do. It’s us.”
That’s the hidden triumph: patients didn’t have to become experts in logistics because the team built the logistics around them.

3) The one-caregiver rule. For families, limiting visitors can feel like losing part of their coping system.
A parent with a newly diagnosed child hears: “Only one adult can come in.” The words are simple; the impact is not.
The team adapts with small merciesFaceTime during rounds, written summaries after visits, and intentional check-ins that acknowledge
the emotional weight of being the “designated strong person” every single day.

4) The telehealth truth test. Video visits can be greatuntil they aren’t. A patient tries to describe shortness of breath:
“It’s not terrible, but it’s… different.” The clinician knows that “different” is sometimes the earliest warning sign.
The plan shifts immediately: “I want you in today.” Telehealth isn’t a replacement for medicine; it’s a triage tool.
When it works, it saves time and exposure. When it doesn’t, it still does something valuable: it speeds up the decision to bring someone in.

5) The clinical trial that refuses to quit. A participant lives hours away. Travel becomes risky and unpredictable.
Instead of dropping out, the trial team coordinates local labs, remote consent updates, and shipping an oral study medication when appropriate.
A monitor reviews records remotely. The patient says, “I didn’t think research could be this flexible.”
The research team thinks the same thingand quietly wonders why it took a pandemic to reduce barriers that had always been there.

The common thread in these experiences isn’t perfection. It’s responsiveness. Cancer care during a pandemic worked best when clinics treated uncertainty like
a clinical variable: real, trackable, and manageable with the right systems. Patients didn’t need a promise that everything would be easy.
They needed proofone appointment at a timethat the team could still show up, still plan, still adjust, and still fight for outcomes.